Stockreport

AbbVie Inc. (ABBV) Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI Subcutaneous Induction in Patients with Crohn's Disease [Yahoo! Finance]

AbbVie Inc.  (ABBV) 
Last abbvie inc. earnings: 5/1 07:43 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
PDF AbbVie Inc. (NYSE: ABBV ) is one of the best undervalued stocks to invest in right now AbbVie Inc. (ABBV) Announces Positive Topline Results from Phase 3 AFFIRM Study [Read more]